№ files_lp_3_process_7_052220
Information sheet for adolescents aged 16–18 outlining the design, purpose, procedures, risks, and follow-up of a UK-based randomised controlled clinical trial evaluating eculizumab for STEC HUS.
Trial Title: Eculizumab in Shiga-Toxin Producing E. Coli Haemolytic Uraemic Syndrome (ECUSTEC): A Randomised, Double-Blind, Placebo-Controlled Trial
Acronym: ECUSTEC
Type of Document: Patient Information Sheet
Study Design: Randomised, Double-Blind, Placebo-Controlled Trial
Medical Condition: Shiga-Toxin Producing E. Coli Haemolytic Uraemic Syndrome (STEC HUS)
Investigational Medicinal Product: Eculizumab
Comparator: Placebo
Target Population: Children and Young People Aged 16–18 Years Diagnosed with STEC HUS
Sample Size: 134 Participants
Geographical Scope: United Kingdom
Study Duration: Four Years Recruitment with 12 Months Follow-Up per Participant
Co-ordinating Centre: Birmingham Clinical Trials Unit (BCTU)
Intervention Schedule: Two Doses Within One Week, First Dose Within 48 Hours of Admission
Primary Objective: To Assess Whether Eculizumab Reduces Disease Severity in STEC HUS
Consent Requirement: Written Informed Consent Required
Voluntary Participation: Yes
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.